Connection

Fengcai Zhu to Neisseria meningitidis, Serogroup A

Back to Details
This is a "connection" page, showing publications Fengcai Zhu has written about Neisseria meningitidis, Serogroup A.
Fengcai Zhu
Connection Strength
0.177
Neisseria meningitidis, Serogroup A
  1. The immunogenicity and safety of a Hib-MenAC vaccine: a non-inferiority randomized, observer-blind trial in infants aged 3-5 months. Expert Rev Vaccines. 2017 May; 16(5):515-524.
    View in: PubMed
    Score: 0.177
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.